Effect of radiotherapy on expression of hyaluronan and EGFR and presence of mast cells in squamous cell carcinoma of the head and neck

Oncology Letters

Volumn 4, Issue 6, 2012, Pages 1177-1182

  Jonsson, Eva Lindell ^a   Nylander, Karin ^a   Hallén, Lars ^a   Laurell, Göran ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Antibodies; Antigens; Epidermal growth factor; Head and neck neoplasm; Humans; Hyaluronan; Immunology; Monoclonal; Paraffin embedding; Protein; Receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HYALURONIC ACID;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; PROTEIN EXPRESSION; RADIATION RESPONSE; TREATMENT RESPONSE;

EID: 84867238711     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.907     Document Type: Article

References (43)

1. Murdoch D: Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review. Curr Opin Oncol 19: 216-221, 2007.
2. Kim ES, Kies M and Herbst RS: Novel therapeutics for head and neck cancer. Curr Opin Oncol 14: 334-342, 2002.
3. Toole BP: Hyaluronan in morphogenesis. Semin Cell Dev Biol 12: 79-87, 2001.
4. Heldin P, Karousou E, Bernert B, Porsch H, Nishitsuka K and Skandalis SS: Importance of hyaluronan-CD44 interactions in inflammation and tumorigenesis. Connect Tissue Res 49: 215-218, 2008.
5. Simpson MA, Weigel JA and Weigel PH: Systemic blockade of the hyaluronan receptor for endocytosis (HARE) prevents lymph node metastasis of prostate cancer. Int J Cancer 131: E836-E840, 2012.
6. Wang SJ and Bourguignon LY: Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg 132: 771-778, 2006.
7. Ekberg T, Nestor M, Engström M, Nordgren H, Wester K, Carlsson J and Anniko M: Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue. Int J Oncol 26: 1177-1185, 2005.
8. Mendelsohn J and Baselga J: Epidermal growth factor receptor targeting in cancer. Semin Oncol 33: 369-385, 2006.
9. Riesterer O, Milas L and Ang KK: Combining molecular therapeutics with radiotherapy for head and neck. J Surg Oncol 97: 708-711, 2008.
10. Dassonville O, Formento JL, Francoual M, Ramaioli A, Santini J, Schneider M, Demard F and Milano G: Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 11: 1873-1878, 1993.
11. Bourguignon LY, Earle C, Wong G, Spevak CC and Krueger K: Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene 31: 149-160, 2012.
12. Junankar SR, Eichten A, Kramer A, de Visser KE and Coussens LM: Analysis of immune cell infiltrates during squamous carcinoma development. J Investig Dermatol Symp Proc 11: 36-43, 2006.
13. Parizi AC, Barbosa RL, Parizi JL and Nai GA: A comparison between the concentration of mast cells in squamous cell carcinomas of the skin and oral cavity. An Bras Dermatol 85: 811-818, 2010.
14. Hellström S, Tengblad A, Johansson C, Hedlund U and Axelsson E: An improved technique for hyaluronan histochemistry using microwave irradiation. Histochem J 22: 677-682, 1990.
15. Melrose J, Tammi M and Smith S: Visualisation of hyaluronan and hyaluronan-binding proteins within ovine vertebral cartilages using biotinylated aggrecan G1-link complex and biotinylated hyaluronan oligosaccharides. Histochem Cell Biol 117: 327-333, 2002.
16. Kersemaekers AM, Fleuren GJ, Kenter GG, Van den Broek LJ, Uljee SM, Hermans J and Van de Vijver MJ: Oncogene alterations in carcinomas of the uterine cervix: overexpression. Clin Cancer Res 5: 577-586, 1999.
17. Wang C, Tammi M, Guo H and Tammi R: Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol 148: 1861-1869, 1996.
18. Inoue M and Katakami C: The effect of hyaluronic acid on corneal epithelial cell proliferation. Invest Ophthalmol Vis Sci 34: 2313-2315, 1993.
19. Laurent C, Johnson-Wells G, Hellström S, Engström-Laurent A and Wells AF: Localization of hyaluronan in various muscular tissues. Cell Tissue Res 263: 201-205, 1991.
20. Erickson M and Stern R: Chain gangs: new aspects of hyaluronan metabolism. Biochem Res Int 2012: 893947, 2012.
21. Mahipal A, Mcdonald MJ, Witkiewicz A and Carr BI: Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma. Med Oncol 29: 134-139, 2011.
22. Noordhuis MG, Eijsink JJ, Ten Hoor KA, et al: Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer. Clin Cancer Res 15: 7389-7397, 2009.
23. Kong Q, Majeska RJ and Vazquez M: Migration of connective tissue-derived cells is mediated by ultra-low concentration gradient fields of EGF. Exp Cell Res 317: 1491-1502, 2011.
24. Pickhard AC, Margraf J, Knopf A, et al: Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways. BMC Cancer 11: 388, 2011
25. Hollenberg MD and Cuatrecasas P: Epidermal growth factor: receptors in human fibroblasts and modulation of action by cholera toxin. Proc Natl Acad Sci USA 70: 2964-2968, 1973.
26. Carpenter G, Lembach KJ, Morrison MM and Cohen S: Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts. J Biol Chem 250: 4297-4304, 1975.
27. Yagi M, Sato N, Mitsui Y, et al: Hyaluronan modulates proliferation and migration of rabbit fibroblasts derived from flexor tendon epitenon and endotenon. J Hand Surg Am 35: 791-796, 2010.
28. Arteaga CL: Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 7: 31-39, 2002.
29. Blick SK and Scott LJ: Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer. Drugs 67: 2585-2607, 2007.
30. Ropponen K, Tammi M, Parkkinen J, et al: Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 58: 342-347, 1998.
31. Kasten-Pisula U, Saker J, Eicheler W, et al: Cellular and tumor radiosensitivity is correlated to epidermal growth factor receptor protein expression level in tumors without EGFR amplification. Int J Radiat Oncol Biol Phys 80: 1181-1188, 2011.
32. Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11: 21-28, 2010.
33. Daar E, King L, Nisbet A, et al: Viscosity changes in hyaluronic acid: irradiation and rheological studies. Appl Radiat Isot 68: 746-750, 2010.
34. Wu Y, Zhao Q, Peng C, et al: Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J Pathol 225: 438-447, 2011.
35. Balkwill F and Mantovani A: Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther 87: 401-406, 2010.
36. Coussens LM, Raymond WW, Bergers G, et al: Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13: 1382-1397, 1999.
37. Ribatti D, Ennas MG, Vacca A, et al: Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest 33: 420-425, 2003.
38. Sawatsubashi M, Yamada T, Fukushima N, et al: Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch 436: 243-248, 2000.
39. Imada A, Shijubo N, Kojima H, et al: Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J 15: 1087-1093, 2000.
40. Nilsson K, Henriksson R, Hellström S, et al: Hyaluronan reflects the pre-fibrotic inflammation in irradiated rat lung: concomitant analysis of parenchymal tissues and bronchoalveolar lavage. Int J Radiat Biol 58: 519-530, 1990.
41. Nilsson K, Bjermer L, Hellström S, et al: A mast cell secretagogue, compound 48/80, prevents the accumulation of hyaluronan in lung tissue injured by ionizing irradiation. Am J Respir Cell Mol Biol 2: 199-205, 1990.
42. Bollyky PL, Falk BA, Wu RP, et al: Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. J Leukoc Biol 86: 567-572, 2009.
43. Boldrup L, Coates PJ, Laurell G and Nylander K: Differences in p63 expression in SCCHN tumours of different sub-sites within the oral cavity. Oral Oncol 47: 861-865, 2011.